Three trials were published comparing reboxetine against other antidepressants in which reboxetine was just as good, and they were published, but three times as many patients' worth of data was collected which showed that reboxetine was worse than those other treatments, and those trials were not published.
三项发表的试验记载 在瑞波西汀和其他抗抑郁药物的对比中，瑞波西汀 效果同样显著，并得以发表， 而另外收集的多达三倍的病例数据 显示瑞波西汀的表现 远不如其它药物的疗效，而这些试验结果没有被发表。